Breaking News Instant updates and real-time market news.

JELD

Jeld-Wen

$21.31

-0.04 (-0.19%)

16:22
10/15/18
10/15
16:22
10/15/18
16:22

Jeld-Wen reports preliminary Q3 revenue $1.13B-$1.14B, consensus $1.16B

Reports preliminary Q3 adjusted EBITDA $130M-$135M, improved compared to $128.2M in the same period a year ago, but below the company's previous outlook of $143M-$153M. The company said that Q3 results were negatively affected by lower than expected revenues and related operational inefficiencies in North America and Europe, as well as from unfavorable channel mix impacting price realization.

JELD Jeld-Wen
$21.31

-0.04 (-0.19%)

10/09/18
NOMU
10/09/18
NO CHANGE
Target $75
NOMU
Buy
Masonite price target lowered to $75 fro $86 at Nomura Instinet
Nomura Instinet analyst Michael Wood lowered his price target for Masonite (DOOR) to $75 saying the District Court for the Eastern District of Virginia's preliminary, unfavorable ruling against Jeld-Wen (JELD) adds uncertainty. The analyst, however, keeps a Buy rating on Masonite shares.
10/08/18
10/08/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kimberly-Clark (KMB) downgraded to Neutral from Buy at Goldman Sachs with analyst Jason English saying his fundamental thesis, that the company's personal care organic sales momentum could sustain and pulp cost pressure was poised to abate, "proved flawed." 2. Waters (WAT) downgraded to Market Perform from Outperform at Leerink. 3. Jeld-Wen (JELD) downgraded to Neutral from Outperform at Baird with analyst Timothy Wojs saying the stock will likely be under some pressure following a ruling late Friday that may result in a divestiture of the company's Towanda, PA facility. 4. Asur (ASR) downgraded to Reduce from Hold at HSBC. 5. Glu Mobile (GLUU) downgraded to Neutral from Buy at Roth Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/08/18
RBCM
10/08/18
NO CHANGE
Target $28
RBCM
Outperform
Jeld-Wen price target lowered to $28 from $35 at RBC Capital
RBC Capital analyst Mike Dahl lowered his price target on Jeld-Wen to $28 following the latest decision by the U.S. District Court for the Eastern District of Virginia mandating the divestiture of its Towanda facility as a "appropriate remedy" in the antitrust litigation. The analyst note that some of the recent weakness in the stock price may have reflected this expectation, but still sees the development as a negative one. Dahl also keeps his Outperform rating on Jeld-Wahl, anticipating no major financial impact from the ruling until 2020 while also pointing to the generation of significant inflow of cash from the sale which can be used on investments to improve productivity at the remaining sites.
10/08/18
BARD
10/08/18
DOWNGRADE
Target $23
BARD
Neutral
Baird sees litigation capping Jeld-Wen upside, downgrades to Neutral
Baird analyst Timothy Wojs downgraded Jeld-Wen to Neutral from Outperform and lowered his price target for the shares to $23 from $34. The stock will likely be under some pressure today following a ruling late Friday that may result in a divestiture of the company's Towanda, PA facility, Wojs tells investors in a research note. The analyst thinks the overhang from Steves litigation will cap the stock's upside over the near term, while 2019 EBITDA estimates "are still not fully washed out." As such, he believes Jeld-Wen shares will remain range bound pending better visibility.

TODAY'S FREE FLY STORIES

TRP

TC Energy

$51.17

0.14 (0.27%)

05:55
11/22/19
11/22
05:55
11/22/19
05:55
Conference/Events
TC Energy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

SPLK

Splunk

$126.80

-0.04 (-0.03%)

05:54
11/22/19
11/22
05:54
11/22/19
05:54
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

PSTG

Pure Storage

$19.84

-0.22 (-1.10%)

05:52
11/22/19
11/22
05:52
11/22/19
05:52
Recommendations
Pure Storage analyst commentary  »

Pure Storage Q3 results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

  • 12

    Dec

  • 10

    Mar

  • 11

    Mar

VNTR

Venator Materials

$3.85

0.055 (1.45%)

05:48
11/22/19
11/22
05:48
11/22/19
05:48
Downgrade
Venator Materials rating change  »

Venator Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$111.26

3 (2.77%)

05:46
11/22/19
11/22
05:46
11/22/19
05:46
Recommendations
Alnylam analyst commentary  »

Alnylam should be sold on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 04

    Feb

QD

Qudian

$4.07

-0.52 (-11.33%)

05:37
11/22/19
11/22
05:37
11/22/19
05:37
Conference/Events
Qudian to host investor update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

LB

L Brands

$17.18

1.18 (7.38%)

05:36
11/22/19
11/22
05:36
11/22/19
05:36
Upgrade
L Brands rating change  »

L Brands upgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 27

    Feb

IFF

International Flavors

$136.82

0.38 (0.28%)

05:35
11/22/19
11/22
05:35
11/22/19
05:35
Upgrade
International Flavors rating change  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$146.25

-3.43 (-2.29%)

05:32
11/22/19
11/22
05:32
11/22/19
05:32
Initiation
ResMed initiated  »

ResMed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORGO

Organogenesis

$6.09

-1.16 (-16.00%)

05:32
11/22/19
11/22
05:32
11/22/19
05:32
Syndicate
Organogenesis 9M share Secondary priced at $5.00 »

Credit Suisse and SVB…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

AMKBY

AP Moller Maersk

$0.00

(0.00%)

05:31
11/22/19
11/22
05:31
11/22/19
05:31
Downgrade
AP Moller Maersk rating change  »

AP Moller Maersk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$19.65

0.04 (0.20%)

05:29
11/22/19
11/22
05:29
11/22/19
05:29
Downgrade
TechnipFMC rating change  »

TechnipFMC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZUN

Baozun

$35.90

-7.59 (-17.45%)

05:26
11/22/19
11/22
05:26
11/22/19
05:26
Downgrade
Baozun rating change  »

Baozun downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTA

Enanta

$63.27

1.55 (2.51%)

05:26
11/22/19
11/22
05:26
11/22/19
05:26
Downgrade
Enanta rating change  »

Enanta downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVO

Novo Nordisk

$54.01

-0.44 (-0.81%)

05:25
11/22/19
11/22
05:25
11/22/19
05:25
Downgrade
Novo Nordisk rating change  »

Novo Nordisk downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

LRENY

Lojas Renner

$0.00

(0.00%)

05:24
11/22/19
11/22
05:24
11/22/19
05:24
Upgrade
Lojas Renner rating change  »

Lojas Renner upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRMK

Broadmark Realty Capital

$10.94

-0.02 (-0.18%)

05:20
11/22/19
11/22
05:20
11/22/19
05:20
Initiation
Broadmark Realty Capital initiated  »

Broadmark Realty Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHM

Autohome

$70.52

0.535 (0.76%)

05:19
11/22/19
11/22
05:19
11/22/19
05:19
Hot Stocks
Autohome appoints Xiao Wang as Chief Technology Officer »

Autohome announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$270.01

-3.38 (-1.24%)

05:18
11/22/19
11/22
05:18
11/22/19
05:18
Recommendations
Intuit analyst commentary  »

Intuit Q2 guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

JELD

Jeld-Wen

$20.61

-0.3 (-1.43%)

05:17
11/22/19
11/22
05:17
11/22/19
05:17
Hot Stocks
Jeld-Wen will appeal latest ruling in Steves litigation »

Jeld-Wen responded to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$126.80

-0.04 (-0.03%)

05:15
11/22/19
11/22
05:15
11/22/19
05:15
Recommendations
Splunk price target raised to $165 from $157 at Jefferies »

Jefferies analyst Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

NFLX

Netflix

$311.88

6.95 (2.28%)

, DIS

Disney

$146.91

0.09 (0.06%)

05:12
11/22/19
11/22
05:12
11/22/19
05:12
Recommendations
Piper survey finds one third of U.S. Netflix subscribers want Disney+ »

Disney's (DIS)…

NFLX

Netflix

$311.88

6.95 (2.28%)

DIS

Disney

$146.91

0.09 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

NPPRF

Nippon Ceramic

$0.00

(0.00%)

05:06
11/22/19
11/22
05:06
11/22/19
05:06
Downgrade
Nippon Ceramic rating change  »

Nippon Ceramic downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTDKY

TDK Corporation

$0.00

(0.00%)

05:04
11/22/19
11/22
05:04
11/22/19
05:04
Upgrade
TDK Corporation rating change  »

TDK Corporation upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRAAY

Murata Manufacturing

$0.00

(0.00%)

05:03
11/22/19
11/22
05:03
11/22/19
05:03
Upgrade
Murata Manufacturing rating change  »

Murata Manufacturing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.